DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Jabbour SA, Frías JP, Ahmed A. et al.
Efficacy and safety over 2 years of exenatide plus dapagliflozin in the DURATION-8 study: a multicenter, double-blind, phase 3, randomized controlled trial.
Diabetes Care 2020;
43 (10) 2528-2536
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.